Composition combination containing enriched hill shaddock oil
US-2024325485-A1 · Oct 3, 2024 · US
US2016374381A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016374381-A1 |
| Application number | US-201615247070-A |
| Country | US |
| Kind code | A1 |
| Filing date | Aug 25, 2016 |
| Priority date | Apr 13, 2011 |
| Publication date | Dec 29, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A nutritional composition is provided which has an effective prophylactic and/or improving effect for various symptoms of muscle mass decrease, decreased basal metabolism, low body temperature, suppression of obesity, suppression of visceral fat accumulation, hyperglycemia, hyperlipidemia and the like in elderly people. The nutritional composition can include n-3 fatty acid and one or more of free lysine, dipeptides containing lysine, and lysine salts, wherein the content of free lysine, dipeptides containing lysine, and/or lysine salts is 0.1 g-10.0 g per 100 kcal of the composition, and the content of the total amount of n-3 fatty acid is 0.17 g-5.00 g per 100 kcal of the composition.
Opening claim text (preview).
1 . A method for decreasing visceral fat or increasing energy consumption, comprising administering an effective amount of a composition comprising: i) n-3 fatty acid, and ii) an ingredient selected from the group consisting of free lysine, dipeptides containing lysine and lysine salts, and combinations thereof; wherein the ingredient is present in the composition in an amount of 0.1 g-10.0 g per 100 kcal of the composition, and wherein the n-3 fatty acid is present in the composition in an amount of 0.17 g-5.00 g per 100 kcal of the composition.
Nutrients, e.g. vitamins, minerals · CPC title
Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P7/00) · CPC title
Drugs for disorders of the muscular or neuromuscular system · CPC title
Tocopherols, e.g. vitamin E · CPC title
Promoters of weight control and weight loss · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.